The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed upcoming new therapies for relapsing MS.
Jeffrey Cohen, MD
Advertisement
Director of the Mellen Center for MS Treatment and Research at Cleveland Clinic.
Articles by Jeffrey Cohen, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
4
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
5
